Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
- PMID: 32853545
- PMCID: PMC7430299
- DOI: 10.1016/j.immuni.2020.08.003
Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
Abstract
Men present more frequently with severe manifestations of coronavirus disease 2019 (COVID-19) and are at higher risk for death. The underlying mechanisms for these differences between female and male individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are insufficiently understood. However, studies from other viral infections have shown that females can mount stronger immune responses against viruses than males. Emerging knowledge on the basic biological pathways that underlie differences in immune responses between women and men needs to be incorporated into research efforts on SARS-CoV-2 pathogenesis and pathology to identify targets for therapeutic interventions aimed at enhancing antiviral immune function and lung airway resilience while reducing pathogenic inflammation in COVID-19.
Keywords: COVID-19; SARS-CoV-2; immune responses; sex differences; tissue regeneration.
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures
References
-
- Baden R., Rockstroh J.K., Buti M. Natural history and management of hepatitis C: does sex play a role? J. Infect. Dis. 2014;209(Suppl 3):S81–S85. - PubMed
-
- Berghöfer B., Frommer T., Haley G., Fink L., Bein G., Hackstein H. TLR7 ligands induce higher IFN-alpha production in females. J. Immunol. 2006;177:2088–2096. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
